Bromodiphenhydramine

Bromodiphenhydramine

Gene therapy
Clinical data
Routes of administration	Oral
ATC code	R06AA01 (WHO)
Physiological data
Legal status
Pharmacokinetic data
Bioavailability	High
Protein binding	96%
Metabolism	Mostly hepatic (CYP-mediated), also renal
Elimination half-life	1 to 4 hours
Identifiers
IUPAC name 2-[(4-bromophenyl)-phenylmethoxy]-N,N-dimethylethanamine
CAS Number	118-23-0 1808-12-4 (hydrochloride)
PubChem Template:Abbreviation	2444
DrugBank	APRD00710
Chemical and physical data
Formula	C17H20BrNO
Molar mass	334.251 g/mol
3D model (JSmol)	Interactive image
SMILES CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Bromazine (INN, also known as bromodiphenhydramine) is an antihistamine. It is a brominated derivative of diphenhydramine. The medicinal preparation of the hydrochloride has the brand name Ambrodyl

Template:WikiDoc Sources